Abstract:Objective: To analyze the clinical characteristics of three patients with Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. Methods: Three patients with IPEX syndrome diagnosed at the Children's Hospital of Fudan University from January 24, 2013 to July 29, 2019 were selected as the study subjects. Their clinical features, laboratory investigations and results of genetic testing were summarized. Treatment and prognosis were also explored. Results: All of the three children had developed the disorder during infancy. One child had initial features including diabetes and diabetic ketoacidosis, whilst the other two had initiated by diarrhea. All patients had gastrointestinal involvement, and one was diagnosed as very early onset inflammatory bowel disease by colonoscopy and biopsy. Two children also had endocrine glands involvement. One child had manifested type 1 diabetes and positivity for thyroglobulin and thyroid peroxidase antibodies, though his thyroid function had remained normal. Another one had hypothyroidism and was treated by levothyroxine. Genetic testing revealed that all children had harbored missense variants of the FOXP3 gene, including c.1222G>A (p.V408M), c.767T>C (p.M256T) and c.1021A>G (p.T341A). The clinical symptoms of one patient were alleviated following allogeneic hematopoietic stem cell transplantation. One patient was stable after treatment with infliximab plus insulin, and one child had died of refractory septic shock and multiple organ dysfunction syndrome at 3 months old. Conclusion: FOXP3 gene variant-associated IPEX syndrome may have very early onset and diverse clinical manifestations. For male patients with infantile onset chronic diarrhea, multiple endocrine or multiple system involvement, genetic testing is recommended, which may facilitate early diagnosis, treatment and genetic counseling.

Molecular Feature and Therapeutic Perspectives of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked Syndrome

[Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked Syndrome in Two Cases].

From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation

[Clinical features and genetic analysis of three patients with Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome due to variants of FOXP3 gene]

Identification of unstable regulatory and autoreactive effector T cells that are expanded in patients with FOXP3 mutations

A Structure-Guided Delineation of FOXP3 Regulation Mechanism in IPEX.

Two Case Reports about Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked Syndrome and Literature Review

FOXP3 and Its Partners: Structural and Biochemical Insights into the Regulation of FOXP3 Activity

The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

Expanding the spectrum of IPEX: from new clinical findings to novel treatments

Atypical Late-Onset Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome with Intractable Diarrhea: A Case Report

Foxp3+ Regulatory T Cells: a Protagonist in the “movie’’ of Autoimmune Diseases?

Molecular and biological role of the FOXP3 N-terminal domain in immune regulation by T regulatory/suppressor cells.

Efficient and sustained FOXP3 locus editing in hematopoietic stem cells as a therapeutic approach for IPEX syndrome

FOXP3 Exon 2 Controls Treg Stability and Autoimmunity

The Secret of FOXP3 Downregulation in the Inflammation Condition.

Improving regulatory T cell-based therapy: insights into post-translational modification regulation

Case Report: Eosinophilic Gastritis with Pyloric Stenosis in Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked Syndrome

Molecular Mechanisms Underlying the Regulation and Functional Plasticity of FOXP3 + Regulatory T Cells

Regulatory T Cells: Regulation of Identity and Function

Biochemistry and therapeutic implications of mechanisms involved in FOXP3 activity in immune suppression.